MEDA Pharma GmbH & Co. KG
24 clinical trials · Sponsor
◉ Watch MEDA Pharma GmbH & Co. KG
| Record | Firm | Date |
|---|---|---|
| Azelastine Allergen Chamber - Onset of Action Study (NCT06126952) | MEDA Pharma GmbH & Co. KG | 2023-10-30 |
| Real-world Evidence Study on Cystistat (NCT05544695) | MEDA Pharma GmbH & Co. KG | 2022-10-21 |
| Dymista Allergen Chamber - Onset of Action Study (NCT04652245) | MEDA Pharma GmbH & Co. KG | 2020-12-14 |
| DYmista NAsal Spray in CHInese Patients (NCT03599791) | MEDA Pharma GmbH & Co. KG | 2018-06-29 |
Track MEDA Pharma GmbH & Co. KG automatically
Every clearance here is in the API, with alerts when new ones post.